Moricizine

This classification denotes a cation channel blocker and antiarrhythmic agent with the molecular formula C22H25N3O4S, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 2GT1D0TMX1, chemically known as phenothiazine-2-carbamic acid, 10-(3-morpholinopropionyl)-, ethyl ester but more generally known as moracizine, which bears U.S. National Institutes of Health Compound Identifier 34633. The European Medicines Agency schedules Moracizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09062MIG. The term MORACIZINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 25 , No. 10 1971, List 11). The World Health Organization schedules moracizine in its Anatomical Therapeutic Chemical (ATC) Classification. MORACIZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: CCOC(=O)NC1=CC2=C(C=C1)SC3=CC=CC=C3N2C(=O)CCN4CCOCC4.CL.